Skip to main content

Cost-Effectiveness Analysis in Health Care: Opportunities and Challenges to International Comparisons

  • Chapter
Costs and Benefits in Health Care and Prevention

Abstract

Cost-effectiveness analysis (CEA), properly conceived and properly applied, can provide useful guidance to decisions and decision-makers in health care. Arguments that have been raised against basing medical decisions on tradeoffs between monetary and health values can be addressed if analyses are sensitive to the ethical underpinnings of these arguments and if we are explicit about our studies’ limitations. Foremost among the challenges to CEA is that of capturing meaningful measures of diverse medical outcomes and the perceived values of these outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weinstein, M.C. and Stason, W.B.: Cost-effectiveness of interventions to prevent or treat coronary heart disease. Ann. Rev. Public Health 1985; 6: 41–63

    Article  Google Scholar 

  2. Thompson, M.S., Read J.L., Hutchings, C., Peterson, M., and Harris, E.D., Jr.: The cost-effectiveness of Auranofin: results of a randomized clinical trial. J. Rheumatology, 1985; 15: 35–42

    Google Scholar 

  3. Oster, G. and Epstein, A.M.: Primary prevention and coronary heart disease: the economic benefits of lowering serum cholesterol. AJPH, 1986; 76: 647–656

    Article  CAS  Google Scholar 

  4. Stason, W.B. and Weinstein, M.C.: Allocation of resources to manage hypertension. N Engl. J. Med 1977; 296: 732–739

    Article  PubMed  CAS  Google Scholar 

  5. Lipid Research Clinics Program. The Lipids Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in incidence of coronary heart disease, 1984; J. Am. Med Assn. 251: 351–364

    Article  Google Scholar 

  6. Berwick, D.M., Cretin, S. and Keeler, E.: Cholesterol, Children, and Heart Disease: An Analysis of Alternatives. 1980. Oxford Univ. Press, New York

    Google Scholar 

  7. Fineberg, H., Scadden, D. and Goldman, L.: Management of patients with a low probability of acute myocardial infarction: cost-effectiveness of alternatives to coronary care unit admission. N. Engl. J. Med. 1984; 310: 1301–1307

    Article  PubMed  CAS  Google Scholar 

  8. Urban, N., Bergner, L., Eisenberg, M.S.: The costs of a suburban paramedic program in reducing deaths due to cardiac arrest. Med. Care 1981; 19: 379–392

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stason, W.B. (1990). Cost-Effectiveness Analysis in Health Care: Opportunities and Challenges to International Comparisons. In: Laaser, U., Roccella, E.J., Rosenfeld, J.B., Wenzel, H. (eds) Costs and Benefits in Health Care and Prevention. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75781-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-75781-5_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-52708-4

  • Online ISBN: 978-3-642-75781-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics